Reply to: Successful Isatuximab Desensitization in a Patient With Refractory Multiple Myeloma and Indolent Systemic Mastocytosis

J Investig Allergol Clin Immunol. 2024 Jan 26:0. doi: 10.18176/jiaci.0992. Online ahead of print.NO ABSTRACTPMID:38275249 | DOI:10.18176/jiaci.0992
Source: Journal of Investigational Allergology and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research